Cargando…
Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3
Hyaluronan (HA) is an abundant matrix molecule whose functions in the skin remain to be fully defined. To explore the roles of HA in cutaneous injury responses, double-knockout mice (abbreviated as Has1/3 null) that lack two HA synthase enzymes (Has1 and Has3) but still express functional Has2, were...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360468/ https://www.ncbi.nlm.nih.gov/pubmed/21850020 http://dx.doi.org/10.1038/jid.2011.248 |
_version_ | 1782234014270095360 |
---|---|
author | Mack, Judith A. Feldman, Ron J. Itano, Naoki Kimata, Koji Lauer, Mark Hascall, Vincent C. Maytin, Edward V. |
author_facet | Mack, Judith A. Feldman, Ron J. Itano, Naoki Kimata, Koji Lauer, Mark Hascall, Vincent C. Maytin, Edward V. |
author_sort | Mack, Judith A. |
collection | PubMed |
description | Hyaluronan (HA) is an abundant matrix molecule whose functions in the skin remain to be fully defined. To explore the roles of HA in cutaneous injury responses, double-knockout mice (abbreviated as Has1/3 null) that lack two HA synthase enzymes (Has1 and Has3) but still express functional Has2, were used in two types of experiments: (i) application of 12-O-tetradecanoylphorbol-13-acetate (TPA), and (ii) full-thickness wounding of the skin. Uninjured Has1/3 null mice were phenotypically normal. However, after TPA, the accumulation of HA that normally occurs in wildtype epidermis was blunted in Has1/3 null epidermis. In excisional wound healing experiments, wound closure was significantly faster in Has1/3 null than in wildtype mice. Coincident with this abnormal wound healing, a marked decrease in epidermal and dermal HA and a marked increase in neutrophil efflux from cutaneous blood vessels were observed in Has1/3 null skin relative to wildtype skin. Has1/3 null wounds displayed an earlier onset of myofibroblast differentiation. In summary, selective loss of Has1 and Has3 leads to a pro-inflammatory milieu that favors recruitment of neutrophils and other inflammation-related changes in the dermis. |
format | Online Article Text |
id | pubmed-3360468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
record_format | MEDLINE/PubMed |
spelling | pubmed-33604682012-07-01 Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3 Mack, Judith A. Feldman, Ron J. Itano, Naoki Kimata, Koji Lauer, Mark Hascall, Vincent C. Maytin, Edward V. J Invest Dermatol Article Hyaluronan (HA) is an abundant matrix molecule whose functions in the skin remain to be fully defined. To explore the roles of HA in cutaneous injury responses, double-knockout mice (abbreviated as Has1/3 null) that lack two HA synthase enzymes (Has1 and Has3) but still express functional Has2, were used in two types of experiments: (i) application of 12-O-tetradecanoylphorbol-13-acetate (TPA), and (ii) full-thickness wounding of the skin. Uninjured Has1/3 null mice were phenotypically normal. However, after TPA, the accumulation of HA that normally occurs in wildtype epidermis was blunted in Has1/3 null epidermis. In excisional wound healing experiments, wound closure was significantly faster in Has1/3 null than in wildtype mice. Coincident with this abnormal wound healing, a marked decrease in epidermal and dermal HA and a marked increase in neutrophil efflux from cutaneous blood vessels were observed in Has1/3 null skin relative to wildtype skin. Has1/3 null wounds displayed an earlier onset of myofibroblast differentiation. In summary, selective loss of Has1 and Has3 leads to a pro-inflammatory milieu that favors recruitment of neutrophils and other inflammation-related changes in the dermis. 2011-08-18 2012-01 /pmc/articles/PMC3360468/ /pubmed/21850020 http://dx.doi.org/10.1038/jid.2011.248 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Mack, Judith A. Feldman, Ron J. Itano, Naoki Kimata, Koji Lauer, Mark Hascall, Vincent C. Maytin, Edward V. Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3 |
title | Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3 |
title_full | Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3 |
title_fullStr | Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3 |
title_full_unstemmed | Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3 |
title_short | Enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases Has1 and Has3 |
title_sort | enhanced inflammation and accelerated wound closure following tetraphorbol ester application or full-thickness wounding in mice lacking hyaluronan synthases has1 and has3 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360468/ https://www.ncbi.nlm.nih.gov/pubmed/21850020 http://dx.doi.org/10.1038/jid.2011.248 |
work_keys_str_mv | AT mackjuditha enhancedinflammationandacceleratedwoundclosurefollowingtetraphorbolesterapplicationorfullthicknesswoundinginmicelackinghyaluronansynthaseshas1andhas3 AT feldmanronj enhancedinflammationandacceleratedwoundclosurefollowingtetraphorbolesterapplicationorfullthicknesswoundinginmicelackinghyaluronansynthaseshas1andhas3 AT itanonaoki enhancedinflammationandacceleratedwoundclosurefollowingtetraphorbolesterapplicationorfullthicknesswoundinginmicelackinghyaluronansynthaseshas1andhas3 AT kimatakoji enhancedinflammationandacceleratedwoundclosurefollowingtetraphorbolesterapplicationorfullthicknesswoundinginmicelackinghyaluronansynthaseshas1andhas3 AT lauermark enhancedinflammationandacceleratedwoundclosurefollowingtetraphorbolesterapplicationorfullthicknesswoundinginmicelackinghyaluronansynthaseshas1andhas3 AT hascallvincentc enhancedinflammationandacceleratedwoundclosurefollowingtetraphorbolesterapplicationorfullthicknesswoundinginmicelackinghyaluronansynthaseshas1andhas3 AT maytinedwardv enhancedinflammationandacceleratedwoundclosurefollowingtetraphorbolesterapplicationorfullthicknesswoundinginmicelackinghyaluronansynthaseshas1andhas3 |